Cytotoxic and toxicological characteristics of oxidation-reduction dendrimers


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Oxidation-reduction dendrimers can produce anion-radicals, that is singlet oxygen and hydrogen peroxide. In this study toxicity of newly synthesized REDOX-dendrimer (RD) in mammalian cells in vitro and in vivo were preliminary evaluated. Objective: toxicity assessment of new RD for mammalian cells in vitro and in vivo. Materials and methods. Cytotoxicity studies of RD was made with MTT and direct living cells counting methods in Syrian hamster embryonic fibroblasts, modified with Src gene (HETR-SR); Syrian hamster embryonic fibroblasts, modified with NRAS gene (HEТR-NRAS); Chinese hamster ovary cancer cell line CHO-K1; erythroid human leukosis K562 and it’s subclone K562/iS9. In vivo toxicity was evaluated in healthy BDF mice using single intraperitoneal injection. Results. RD studies showed that it effectively influences cell lines with different catalase activity. 50 % growth inhibition (1C%) was observed at concentration of RD: 6,871E-09- 7,031E-09 М - for HEТR-NRAS; 1,64E-08-1,78E-08 М - for HETR-SR; 2,92E-08- 3,06E-08 M-for СНО-К1 strain. For K562/iS9 and К562 IC50 value was within the range from 1,698Е-005 to 2,606Е-005 М and from 1,288Е-005 to 1,722Е-005 М, respectively. Acute toxicity studies in mice showed that LD10 = 948 + 4 mg/kg and LD50 = 1000 + 21 (958 - 1043) mg/kg. Conclusion. New RD was studied in this research both in vitro and in vivo. It’s toxic parameters were determined in mammalian cells with different catalase strength. Obtained values of IC50 ≤10-4 М show that studied RD is cytotoxic. Acute toxicity studies in mice showed that RD influence on animals is dose dependant.

About the authors

E. Yu. Grigor’Eva

N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia

Author for correspondence.
Email: grig-elen11@mail.ru
Russian Federation

Yu. V. Stukalov

N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia

Russian Federation

E. Yu. Koldaeva

N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia

Russian Federation

M. I. Lukashina

Institute of Gene Biology, Russian Academy of Sciences

Russian Federation

T. A. Sidorova

N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia

Russian Federation

A. S. Mas’Ko

N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia

Russian Federation

N. V. Pozdnyakova

N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-53039 от  04.03.2013.